Processa Pharmaceuticals, Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Processa Pharmaceuticals, Inc. (PCSA) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$12.35 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-09-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-12-31 was -$21.16K, a 189.17% decline year-over-year.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-09-30 was $17.57K.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-06-30 was -$2.30K.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-03-31 was -$6.47K.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2016 was -$12.35K.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2015 was -$232.36K.
- Processa Pharmaceuticals, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2014 was -$779.60K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-12-31 | -$21.16K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$3.58K derived: sum of 2 quarters · filed 2017-11-20 | -$5.88K derived: sum of 3 quarters · filed 2017-11-20 | -$12.35K 10-K · filed 2017-09-25 | ||
| 2016-09-30 | $17.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $15.28K derived: sum of 2 quarters · filed 2017-11-20 | $8.81K 10-Q · filed 2017-11-20 | -$8.81K 10-Q · filed 2017-09-08 | $32.53K derived: sum of 4 quarters · filed 2017-11-20 | |
| 2016-06-30 | -$2.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | -$8.77K 10-Q · filed 2017-10-04 | $14.96K derived: sum of 3 quarters · filed 2017-10-04 | -$4.41K derived: sum of 4 quarters · filed 2017-10-04 | ||
| 2016-03-31 | -$6.47K 10-Q · filed 2017-10-04 | $17.26K derived: sum of 2 quarters · filed 2017-10-04 | -$2.11K derived: sum of 3 quarters · filed 2017-10-04 | -$89.58K derived: sum of 4 quarters · filed 2017-10-04 | ||
| 2015-12-31 | $23.73K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $4.36K derived: sum of 2 quarters · filed 2017-09-25 | -$83.12K derived: sum of 3 quarters · filed 2017-09-25 | -$232.36K 10-K · filed 2017-09-25 | -$231.36K 10-K · filed 2017-06-19 | |
| 2015-09-30 | -$19.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$106.84K derived: sum of 2 quarters · filed 2017-09-08 | -$256.08K 10-Q · filed 2017-09-08 | |||
| 2015-06-30 | -$87.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$236.71K 10-Q · filed 2017-08-30 | ||||
| 2015-03-31 | -$149.24K 10-Q · filed 2017-08-07 | |||||
| 2014-12-31 | -$779.60K 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |